Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis.

Chou YC, Chen CL, Yeh TH, Lin SJ, Chen MR, Doong SL, Lu J, Tsai CH.

Am J Pathol. 2012 Nov;181(5):1773-81. doi: 10.1016/j.ajpath.2012.07.014. Epub 2012 Sep 11.

PMID:
22974584
2.

Requirement for LMP1-induced RON receptor tyrosine kinase in Epstein-Barr virus-mediated B-cell proliferation.

Chou YC, Lin SJ, Lu J, Yeh TH, Chen CL, Weng PL, Lin JH, Yao M, Tsai CH.

Blood. 2011 Aug 4;118(5):1340-9. doi: 10.1182/blood-2011-02-335448. Epub 2011 Jun 9.

3.

Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.

Ho CH, Chen CL, Li WY, Chen CJ.

Carcinogenesis. 2009 Aug;30(8):1443-51. doi: 10.1093/carcin/bgp135. Epub 2009 May 29.

PMID:
19483191
4.

NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.

Verhoeven RJ, Tong S, Zhang G, Zong J, Chen Y, Jin DY, Chen MR, Pan J, Chen H.

J Virol. 2016 Jun 24;90(14):6475-88. doi: 10.1128/JVI.00613-16. Print 2016 Jul 15.

6.
7.

Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.

Lan YY, Hsiao JR, Chang KC, Chang JS, Chen CW, Lai HC, Wu SY, Yeh TH, Chang FH, Lin WH, Su IJ, Chang Y.

J Virol. 2012 Jun;86(12):6656-67. doi: 10.1128/JVI.00174-12. Epub 2012 Apr 18.

8.
9.

Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma.

Horikawa T, Yoshizaki T, Kondo S, Furukawa M, Kaizaki Y, Pagano JS.

Br J Cancer. 2011 Mar 29;104(7):1160-7. doi: 10.1038/bjc.2011.38. Epub 2011 Mar 8.

10.

Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.

Lo AK, Dawson CW, Young LS, Ko CW, Hau PM, Lo KW.

J Pathol. 2015 Oct;237(2):238-48. doi: 10.1002/path.4575. Epub 2015 Aug 3.

PMID:
26096068
11.

Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.

Li J, Zhang XS, Xie D, Deng HX, Gao YF, Chen QY, Huang WL, Masucci MG, Zeng YX.

Cancer Biol Ther. 2007 Dec;6(12):1997-2004. Epub 2007 Oct 13.

PMID:
18087217
12.

Tyrosylprotein sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4 are induced by Epstein-Barr virus encoded latent membrane protein 1 and associated with the metastatic potential of human nasopharyngeal carcinoma.

Xu J, Deng X, Tang M, Li L, Xiao L, Yang L, Zhong J, Bode AM, Dong Z, Tao Y, Cao Y.

PLoS One. 2013;8(3):e56114. doi: 10.1371/journal.pone.0056114. Epub 2013 Mar 5.

13.
14.

Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.

Yu PH, Chou SF, Chen CL, Hung H, Lai CY, Yang PM, Jeng YM, Liaw SF, Kuo HH, Hsu HC, Chen JY, Wang WB.

PLoS One. 2013 Dec 5;8(12):e82254. doi: 10.1371/journal.pone.0082254. eCollection 2013.

15.

Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.

Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, Xiong D, Guan S, Guo BH, Mai HQ, Chen QY, Zhang X, Li MZ, Shao JY, Qian CN, Xia YF, Song LB, Zeng YX, Zeng MS.

PLoS Pathog. 2010 Jun 3;6(6):e1000940. doi: 10.1371/journal.ppat.1000940.

16.

Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.

Liu HP, Chen CC, Wu CC, Huang YC, Liu SC, Liang Y, Chang KP, Chang YS.

PLoS Pathog. 2012;8(5):e1002690. doi: 10.1371/journal.ppat.1002690. Epub 2012 May 10.

17.

Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways.

Zhang J, Jia L, Lin W, Yip YL, Lo KW, Lau VM, Zhu D, Tsang CM, Zhou Y, Deng W, Lung HL, Lung ML, Cheung LM, Tsao SW.

J Virol. 2017 Feb 28;91(6). pii: e02168-16. doi: 10.1128/JVI.02168-16. Print 2017 Mar 15.

18.

Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.

Rosales-Pérez S, Cano-Valdez AM, Flores-Balcázar CH, Guedea-Edo F, Lino-Silva LS, Lozano-Borbalas A, Navarro-Martín A, Poitevin-Chacón A.

Arch Med Res. 2014 Apr;45(3):229-36. doi: 10.1016/j.arcmed.2014.02.002. Epub 2014 Mar 4.

PMID:
24606815
19.

NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.

Chen CC, Liu HP, Chao M, Liang Y, Tsang NM, Huang HY, Wu CC, Chang YS.

Oncogene. 2014 Jul 10;33(28):3648-59. doi: 10.1038/onc.2013.345. Epub 2013 Aug 26.

PMID:
23975427
20.

EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.

Cai LM, Lyu XM, Luo WR, Cui XF, Ye YF, Yuan CC, Peng QX, Wu DH, Liu TF, Wang E, Marincola FM, Yao KT, Fang WY, Cai HB, Li X.

Oncogene. 2015 Apr 23;34(17):2156-66. doi: 10.1038/onc.2014.341. Epub 2014 Oct 27.

PMID:
25347742

Supplemental Content

Support Center